SpicyIP

JANUARY 20, 2022

For further details, please see their announcement below: LexisNexis recognizes the world’s outperforming companies with its “Innovation Momentum 2022: The Global Top 100” report. In addition, the best-performing innovators from academia and public research are recognized and placed in the context of their peer groups.

Reporting 98

Reporting Intellectual Property Technology Business 98

Kashishipr

JUNE 3, 2021

Today, companies are increasingly placing a huge amount of enterprise value on Intellectual Property (IP). In a few instances, the value attributed to IP assets by companies is greater than the entire net worth of the corporation itself. The United States of America. have attracted taxation on IP as a global issue.

Intellectual Property 98

Intellectual Property Ownership IP Licensing 98

SpicyIP

MARCH 21, 2024

In light of the recent Patent (Amendment) Rules, 2024, we are pleased to bring this post by Prashant Reddy T., which was written in the context of the October ’23 draft amendments. Prashant raises questions as to the influence of business lobbying groups, and concerns regarding the then proposed changes to the Rules. Prashant Reddy T.

Patent 52

Patent Patent Application Government Reporting 52

IIPRD

FEBRUARY 23, 2021

A report on “IP Backed Financing – Overview of Trends” by Relecura shows that companies like General Motors, Avago, Alcatel Lucent, Kodak, Freescale, and Seagate have raised significant financing as collateral. It has been seen that such transactions for raising loans are used when companies run out of options to pledge tangible assets.

IP 40

IP Intellectual Property Branding Brands 40

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

Yet 2020 saw a slowdown in biosimilar activity with the lowest number of annual biosimilar approvals since 2016 and fewer product launches than 2019—as well as a decrease in district court litigation and post-grant proceedings. None of these was the first biosimilar for its respective reference product. Biosimilars Approved as of 2020.

Settlement 52

Settlement Litigation Marketing Marketing 52

Trading Secrets

JUNE 3, 2022

In the case, a pharmaceutical company sued a former product development employee and his new employer in the District of New Jersey for misappropriation of trade secrets in violation of the DTSA. This blog post summarizes some of the significant decisions grouped by the hot topics below. In Oakwood Lab’ys LLC v. Thanoo , 999 F.3d

Law 59

Law Confidentiality Designs Design 59

LexBlog IP

AUGUST 12, 2021

A group of senators, led by Senator Amy Klobuchar, are sponsors of a Senate bill which aims to prohibit biological product manufacturers from compensating biosimilar and interchangeable biological companies in exchange for delaying entry of those biosimilar and interchangeable biological products. 1428, 117th Cong.

Settlement 52

Settlement Intellectual Property Law Intellectual Property Reporting 52